NEW YORK, March 2 (Reuters) - U.S. pharmaceutical and medical equipment maker Johnson & Johnson said on Monday it agreed to sell its Cordis vascular technology unit to Cardinal Health for $1.9...
NEW YORK, March 2 (Reuters) - Cardinal Health said on Monday that it would buy Johnson & Johnson's Cordis vascular technology unit for $1.9 billion and that the acquisition would boost 2017 earnings by 20 cents per share.
Cardinal Health announced March 2 that it will acquire Cordis, a cardiology and endovascular ..... to close at the end of 2015 and provide earnings accretion in 2017. Cardinal also stated that it expects the acquisition to produce $100 million
healthcare market that have been profiled in the report include 3M Health Care, Bayer AG, Abbott Laboratories, Cardinal Health , Inc ., GE Healthcare, Johnson & Johnson Services, Inc., Gentiva Health Services, Inc., Invacare Corporation
We think improving macroeconomic conditions and acquisitions, including the recently announced partnership with Cardinal Health , should support high-single-digit growth for the company in 2015 even though currency headwinds will weigh on
Cardinal Health reported fiscal 2015 second-quarter results that were in line with our ..... shift toward smaller customer contracts over the past year. We believe Cardinal ’s strong push to move beyond its core U.S. pharmaceutical distribution
Cardinal Health reported fiscal 2015 first-quarter ..... profits over the long term. Additionally, Cardinal 's strong push to move beyond its core ..... develop over the course of fiscal 2015. Cardinal 's generic sourcing partnership with
the smallest players in the medical distribution field, which is dominated by giants such as McKesson MCK and Cardinal Health CAH . Yet it has persistently increased its market share within the small niche it occupies (the small physician office
Cardinal Health reported fiscal 2014 fourth-quarter results ..... over the long-term. Additionally, Cardinal made a strong push in fiscal 2014 to ..... the drug distributor as it will allow Cardinal to push through greater procurement efficiency
Cardinal Health reported fiscal 2014 third-quarter ..... the drug distributor as it will allow Cardinal to push through greater procurement efficiency--a long-term value driver. Cardinal also announced two material acquisitions